nodes	percent_of_prediction	percent_of_DWPC	metapath
Triflupromazine—BCHE—malignant glioma	0.919	1	CbGaD
Triflupromazine—DRD1—telencephalic ventricle—malignant glioma	0.00921	0.175	CbGeAlD
Triflupromazine—DRD2—telencephalic ventricle—malignant glioma	0.00544	0.103	CbGeAlD
Triflupromazine—DRD1—brainstem—malignant glioma	0.00249	0.0473	CbGeAlD
Triflupromazine—DRD1—telencephalon—malignant glioma	0.00221	0.042	CbGeAlD
Triflupromazine—Trifluoperazine—CALY—malignant glioma	0.0022	0.316	CrCbGaD
Triflupromazine—CHRM2—telencephalon—malignant glioma	0.00178	0.0338	CbGeAlD
Triflupromazine—CHRM1—telencephalon—malignant glioma	0.00162	0.0308	CbGeAlD
Triflupromazine—HTR2B—telencephalon—malignant glioma	0.00161	0.0306	CbGeAlD
Triflupromazine—DRD1—midbrain—malignant glioma	0.00159	0.0301	CbGeAlD
Triflupromazine—DRD2—brainstem—malignant glioma	0.00147	0.0279	CbGeAlD
Triflupromazine—DRD2—retina—malignant glioma	0.00142	0.0269	CbGeAlD
Triflupromazine—BCHE—brainstem—malignant glioma	0.00133	0.0253	CbGeAlD
Triflupromazine—DRD2—telencephalon—malignant glioma	0.00131	0.0248	CbGeAlD
Triflupromazine—DRD1—central nervous system—malignant glioma	0.00126	0.0238	CbGeAlD
Triflupromazine—BCHE—telencephalon—malignant glioma	0.00118	0.0225	CbGeAlD
Triflupromazine—ABCB1—blood vessel—malignant glioma	0.00116	0.0221	CbGeAlD
Triflupromazine—CHRM2—central nervous system—malignant glioma	0.00101	0.0192	CbGeAlD
Triflupromazine—DRD1—brain—malignant glioma	0.000998	0.0189	CbGeAlD
Triflupromazine—DRD2—midbrain—malignant glioma	0.000938	0.0178	CbGeAlD
Triflupromazine—BCHE—medulla oblongata—malignant glioma	0.000931	0.0177	CbGeAlD
Triflupromazine—CHRM1—central nervous system—malignant glioma	0.000922	0.0175	CbGeAlD
Triflupromazine—HTR2B—central nervous system—malignant glioma	0.000917	0.0174	CbGeAlD
Triflupromazine—BCHE—midbrain—malignant glioma	0.000851	0.0161	CbGeAlD
Triflupromazine—BCHE—spinal cord—malignant glioma	0.00083	0.0158	CbGeAlD
Triflupromazine—CHRM2—brain—malignant glioma	0.000804	0.0153	CbGeAlD
Triflupromazine—DRD2—central nervous system—malignant glioma	0.000742	0.0141	CbGeAlD
Triflupromazine—CHRM1—brain—malignant glioma	0.000732	0.0139	CbGeAlD
Triflupromazine—HTR2B—brain—malignant glioma	0.000728	0.0138	CbGeAlD
Triflupromazine—DRD2—cerebellum—malignant glioma	0.000726	0.0138	CbGeAlD
Triflupromazine—ABCB1—embryo—malignant glioma	0.000694	0.0132	CbGeAlD
Triflupromazine—BCHE—central nervous system—malignant glioma	0.000673	0.0128	CbGeAlD
Triflupromazine—BCHE—cerebellum—malignant glioma	0.000658	0.0125	CbGeAlD
Triflupromazine—Ethopropazine—BCHE—malignant glioma	0.000621	0.0894	CrCbGaD
Triflupromazine—ABCB1—retina—malignant glioma	0.000614	0.0116	CbGeAlD
Triflupromazine—DRD2—brain—malignant glioma	0.000589	0.0112	CbGeAlD
Triflupromazine—ABCB1—telencephalon—malignant glioma	0.000565	0.0107	CbGeAlD
Triflupromazine—BCHE—brain—malignant glioma	0.000535	0.0101	CbGeAlD
Triflupromazine—Clomipramine—GSTP1—malignant glioma	0.000521	0.075	CrCbGaD
Triflupromazine—Perphenazine—CYP2C18—malignant glioma	0.000511	0.0735	CrCbGaD
Triflupromazine—Desipramine—CYP2C18—malignant glioma	0.000475	0.0684	CrCbGaD
Triflupromazine—ABCB1—medulla oblongata—malignant glioma	0.000444	0.00842	CbGeAlD
Triflupromazine—ABCB1—midbrain—malignant glioma	0.000405	0.00769	CbGeAlD
Triflupromazine—Imipramine—CYP2C18—malignant glioma	0.000403	0.058	CrCbGaD
Triflupromazine—ABCB1—spinal cord—malignant glioma	0.000396	0.00751	CbGeAlD
Triflupromazine—Promethazine—CYP2B6—malignant glioma	0.000388	0.0559	CrCbGaD
Triflupromazine—Perphenazine—CYP2B6—malignant glioma	0.000379	0.0546	CrCbGaD
Triflupromazine—Desipramine—CYP2B6—malignant glioma	0.000353	0.0508	CrCbGaD
Triflupromazine—ABCB1—central nervous system—malignant glioma	0.000321	0.00609	CbGeAlD
Triflupromazine—ABCB1—cerebellum—malignant glioma	0.000314	0.00595	CbGeAlD
Triflupromazine—Desipramine—SLC6A3—malignant glioma	0.000301	0.0433	CrCbGaD
Triflupromazine—Imipramine—CYP2B6—malignant glioma	0.000299	0.0431	CrCbGaD
Triflupromazine—Imipramine—SLC6A3—malignant glioma	0.000255	0.0367	CrCbGaD
Triflupromazine—ABCB1—brain—malignant glioma	0.000255	0.00484	CbGeAlD
Triflupromazine—Chlorpromazine—BCHE—malignant glioma	0.000245	0.0353	CrCbGaD
Triflupromazine—CHRM1—GPCR downstream signaling—PIK3CB—malignant glioma	7.59e-06	0.000356	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—CDKN2B—malignant glioma	7.55e-06	0.000354	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—EGF—malignant glioma	7.54e-06	0.000354	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—F2—malignant glioma	7.52e-06	0.000353	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—FN1—malignant glioma	7.52e-06	0.000353	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—MMP3—malignant glioma	7.52e-06	0.000353	CbGpPWpGaD
Triflupromazine—CHRM2—GPCR downstream signaling—PIK3CB—malignant glioma	7.49e-06	0.000352	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—PTPN11—malignant glioma	7.49e-06	0.000352	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—PTK2—malignant glioma	7.49e-06	0.000351	CbGpPWpGaD
Triflupromazine—DRD2—GPCR downstream signaling—CXCL8—malignant glioma	7.45e-06	0.00035	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—CDKN2B—malignant glioma	7.45e-06	0.000349	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—BAD—malignant glioma	7.43e-06	0.000348	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—BCHE—malignant glioma	7.4e-06	0.000347	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—HES1—malignant glioma	7.36e-06	0.000345	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—NOTCH1—malignant glioma	7.36e-06	0.000345	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—PTK2—malignant glioma	7.33e-06	0.000344	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—SLC5A5—malignant glioma	7.31e-06	0.000343	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—NCOR1—malignant glioma	7.31e-06	0.000343	CbGpPWpGaD
Triflupromazine—CHRM1—GPCR downstream signaling—CXCL8—malignant glioma	7.3e-06	0.000342	CbGpPWpGaD
Triflupromazine—BCHE—Metabolism—PIK3CD—malignant glioma	7.24e-06	0.00034	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—PTK2—malignant glioma	7.23e-06	0.000339	CbGpPWpGaD
Triflupromazine—DRD2—Signaling by GPCR—RAF1—malignant glioma	7.22e-06	0.000338	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—CD80—malignant glioma	7.21e-06	0.000338	CbGpPWpGaD
Triflupromazine—CHRM2—GPCR downstream signaling—CXCL8—malignant glioma	7.2e-06	0.000338	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—HES1—malignant glioma	7.2e-06	0.000338	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—APC—malignant glioma	7.19e-06	0.000337	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—PIK3CG—malignant glioma	7.19e-06	0.000337	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—BRAF—malignant glioma	7.17e-06	0.000336	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—NCOR1—malignant glioma	7.16e-06	0.000336	CbGpPWpGaD
Triflupromazine—DRD2—GPCR downstream signaling—IL2—malignant glioma	7.12e-06	0.000334	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—EGF—malignant glioma	7.11e-06	0.000334	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—HES1—malignant glioma	7.11e-06	0.000333	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—PTPN11—malignant glioma	7.07e-06	0.000331	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—NCOR1—malignant glioma	7.07e-06	0.000331	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling by GPCR—RAF1—malignant glioma	7.06e-06	0.000331	CbGpPWpGaD
Triflupromazine—DRD2—Signaling by GPCR—PIK3CB—malignant glioma	7.04e-06	0.00033	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—PDGFRA—malignant glioma	7e-06	0.000329	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—AKT2—malignant glioma	6.98e-06	0.000327	CbGpPWpGaD
Triflupromazine—CHRM1—GPCR downstream signaling—IL2—malignant glioma	6.97e-06	0.000327	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling by GPCR—RAF1—malignant glioma	6.97e-06	0.000327	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling by GPCR—EGFR—malignant glioma	6.95e-06	0.000326	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling by GPCR—PIK3CB—malignant glioma	6.89e-06	0.000323	CbGpPWpGaD
Triflupromazine—CHRM2—GPCR downstream signaling—IL2—malignant glioma	6.88e-06	0.000323	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—PDGFRA—malignant glioma	6.85e-06	0.000322	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling by GPCR—PIK3CB—malignant glioma	6.81e-06	0.000319	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—SPP1—malignant glioma	6.8e-06	0.000319	CbGpPWpGaD
Triflupromazine—DRD2—Signaling by GPCR—CXCL8—malignant glioma	6.77e-06	0.000318	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—PDGFRA—malignant glioma	6.77e-06	0.000317	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—BRAF—malignant glioma	6.76e-06	0.000317	CbGpPWpGaD
Triflupromazine—ABCB1—Transmembrane transport of small molecules—RAF1—malignant glioma	6.74e-06	0.000316	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—PIK3CD—malignant glioma	6.71e-06	0.000315	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—SPP1—malignant glioma	6.65e-06	0.000312	CbGpPWpGaD
Triflupromazine—HTR2B—GPCR downstream signaling—PIK3CA—malignant glioma	6.64e-06	0.000312	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling by GPCR—CXCL8—malignant glioma	6.62e-06	0.000311	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—AKT2—malignant glioma	6.58e-06	0.000309	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—SPP1—malignant glioma	6.57e-06	0.000308	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling by GPCR—KRAS—malignant glioma	6.56e-06	0.000308	CbGpPWpGaD
Triflupromazine—DRD1—Signaling by GPCR—EGFR—malignant glioma	6.55e-06	0.000307	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling by GPCR—CXCL8—malignant glioma	6.54e-06	0.000307	CbGpPWpGaD
Triflupromazine—DRD2—Signaling by GPCR—IL2—malignant glioma	6.47e-06	0.000303	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—TERT—malignant glioma	6.45e-06	0.000302	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—FGF2—malignant glioma	6.42e-06	0.000301	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling by GPCR—IL2—malignant glioma	6.33e-06	0.000297	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—PIK3CD—malignant glioma	6.32e-06	0.000297	CbGpPWpGaD
Triflupromazine—BCHE—Metabolism—PIK3CB—malignant glioma	6.31e-06	0.000296	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—TERT—malignant glioma	6.31e-06	0.000296	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—PDGFB—malignant glioma	6.29e-06	0.000295	CbGpPWpGaD
Triflupromazine—DRD1—GPCR downstream signaling—PIK3CA—malignant glioma	6.26e-06	0.000294	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—FGFR1—malignant glioma	6.26e-06	0.000294	CbGpPWpGaD
Triflupromazine—BCHE—Metabolism—PTGS2—malignant glioma	6.26e-06	0.000293	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling by GPCR—IL2—malignant glioma	6.25e-06	0.000293	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—TERT—malignant glioma	6.23e-06	0.000292	CbGpPWpGaD
Triflupromazine—DRD1—Signaling by GPCR—KRAS—malignant glioma	6.19e-06	0.00029	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—HIF1A—malignant glioma	6.16e-06	0.000289	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—PDGFB—malignant glioma	6.16e-06	0.000289	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—FGFR1—malignant glioma	6.13e-06	0.000287	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—PDGFB—malignant glioma	6.08e-06	0.000285	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—FGF2—malignant glioma	6.05e-06	0.000284	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—FGFR1—malignant glioma	6.05e-06	0.000284	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—HIF1A—malignant glioma	6.03e-06	0.000283	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling by GPCR—PIK3CA—malignant glioma	6.03e-06	0.000283	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—MDM2—malignant glioma	6.01e-06	0.000282	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—RAF1—malignant glioma	5.99e-06	0.000281	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—CAV1—malignant glioma	5.96e-06	0.00028	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—HIF1A—malignant glioma	5.96e-06	0.000279	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—ERBB2—malignant glioma	5.92e-06	0.000278	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—KDR—malignant glioma	5.9e-06	0.000277	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—GSTP1—malignant glioma	5.89e-06	0.000276	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—PIK3CB—malignant glioma	5.84e-06	0.000274	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—CAV1—malignant glioma	5.83e-06	0.000274	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—KDR—malignant glioma	5.77e-06	0.000271	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—CAV1—malignant glioma	5.76e-06	0.00027	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—CAT—malignant glioma	5.73e-06	0.000269	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—KDR—malignant glioma	5.7e-06	0.000267	CbGpPWpGaD
Triflupromazine—DRD1—Signaling by GPCR—PIK3CA—malignant glioma	5.69e-06	0.000267	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—F2—malignant glioma	5.67e-06	0.000266	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—FN1—malignant glioma	5.67e-06	0.000266	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—MDM2—malignant glioma	5.66e-06	0.000266	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—RAF1—malignant glioma	5.65e-06	0.000265	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—CXCL8—malignant glioma	5.62e-06	0.000263	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—BAD—malignant glioma	5.61e-06	0.000263	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—ERBB2—malignant glioma	5.59e-06	0.000262	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—FN1—malignant glioma	5.55e-06	0.000261	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—F2—malignant glioma	5.55e-06	0.000261	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—NOTCH1—malignant glioma	5.55e-06	0.000261	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—PIK3CB—malignant glioma	5.51e-06	0.000259	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—BAD—malignant glioma	5.49e-06	0.000257	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—FN1—malignant glioma	5.48e-06	0.000257	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—F2—malignant glioma	5.48e-06	0.000257	CbGpPWpGaD
Triflupromazine—BCHE—Metabolism—PTEN—malignant glioma	5.46e-06	0.000256	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—CD80—malignant glioma	5.44e-06	0.000255	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—NOTCH1—malignant glioma	5.43e-06	0.000255	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—PIK3CG—malignant glioma	5.43e-06	0.000255	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—APC—malignant glioma	5.43e-06	0.000255	CbGpPWpGaD
Triflupromazine—HTR2B—GPCR downstream signaling—AKT1—malignant glioma	5.43e-06	0.000255	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—BAD—malignant glioma	5.42e-06	0.000254	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—NCOR1—malignant glioma	5.41e-06	0.000254	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—CASP3—malignant glioma	5.38e-06	0.000252	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—EGF—malignant glioma	5.37e-06	0.000252	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—IL2—malignant glioma	5.37e-06	0.000252	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—NOTCH1—malignant glioma	5.37e-06	0.000252	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—PTPN11—malignant glioma	5.34e-06	0.00025	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—CD80—malignant glioma	5.32e-06	0.00025	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—PIK3CG—malignant glioma	5.31e-06	0.000249	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—APC—malignant glioma	5.31e-06	0.000249	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—CXCL8—malignant glioma	5.3e-06	0.000248	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—CD80—malignant glioma	5.26e-06	0.000247	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—EGF—malignant glioma	5.25e-06	0.000246	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—PIK3CG—malignant glioma	5.25e-06	0.000246	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—APC—malignant glioma	5.25e-06	0.000246	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—PTPN11—malignant glioma	5.22e-06	0.000245	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—EGF—malignant glioma	5.19e-06	0.000243	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—PTPN11—malignant glioma	5.15e-06	0.000242	CbGpPWpGaD
Triflupromazine—DRD1—GPCR downstream signaling—AKT1—malignant glioma	5.12e-06	0.00024	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—BRAF—malignant glioma	5.1e-06	0.000239	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—MMP9—malignant glioma	5.08e-06	0.000238	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—CASP3—malignant glioma	5.07e-06	0.000238	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—IL2—malignant glioma	5.06e-06	0.000237	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—PTEN—malignant glioma	5.05e-06	0.000237	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—BRAF—malignant glioma	5e-06	0.000234	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—AKT2—malignant glioma	4.97e-06	0.000233	CbGpPWpGaD
Triflupromazine—DRD2—Signaling by GPCR—EGFR—malignant glioma	4.95e-06	0.000232	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—BRAF—malignant glioma	4.93e-06	0.000231	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling by GPCR—AKT1—malignant glioma	4.93e-06	0.000231	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—AKT2—malignant glioma	4.86e-06	0.000228	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling by GPCR—EGFR—malignant glioma	4.84e-06	0.000227	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—AKT2—malignant glioma	4.8e-06	0.000225	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—MMP9—malignant glioma	4.79e-06	0.000225	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling by GPCR—EGFR—malignant glioma	4.78e-06	0.000224	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—PIK3CD—malignant glioma	4.77e-06	0.000224	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—PTEN—malignant glioma	4.76e-06	0.000223	CbGpPWpGaD
Triflupromazine—DRD2—GPCR downstream signaling—PIK3CA—malignant glioma	4.73e-06	0.000222	CbGpPWpGaD
Triflupromazine—DRD2—Signaling by GPCR—KRAS—malignant glioma	4.67e-06	0.000219	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—PIK3CD—malignant glioma	4.67e-06	0.000219	CbGpPWpGaD
Triflupromazine—DRD1—Signaling by GPCR—AKT1—malignant glioma	4.65e-06	0.000218	CbGpPWpGaD
Triflupromazine—CHRM1—GPCR downstream signaling—PIK3CA—malignant glioma	4.63e-06	0.000217	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—PIK3CD—malignant glioma	4.61e-06	0.000216	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling by GPCR—KRAS—malignant glioma	4.57e-06	0.000215	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—FGF2—malignant glioma	4.57e-06	0.000214	CbGpPWpGaD
Triflupromazine—CHRM2—GPCR downstream signaling—PIK3CA—malignant glioma	4.57e-06	0.000214	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—VEGFA—malignant glioma	4.56e-06	0.000214	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—STAT3—malignant glioma	4.52e-06	0.000212	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling by GPCR—KRAS—malignant glioma	4.52e-06	0.000212	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—FGF2—malignant glioma	4.47e-06	0.00021	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—FGF2—malignant glioma	4.42e-06	0.000207	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—CAV1—malignant glioma	4.41e-06	0.000207	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—VEGFA—malignant glioma	4.3e-06	0.000202	CbGpPWpGaD
Triflupromazine—DRD2—Signaling by GPCR—PIK3CA—malignant glioma	4.29e-06	0.000201	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—MDM2—malignant glioma	4.28e-06	0.000201	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—RAF1—malignant glioma	4.26e-06	0.0002	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—STAT3—malignant glioma	4.26e-06	0.0002	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—ERBB2—malignant glioma	4.22e-06	0.000198	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling by GPCR—PIK3CA—malignant glioma	4.2e-06	0.000197	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—MYC—malignant glioma	4.2e-06	0.000197	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—MDM2—malignant glioma	4.19e-06	0.000196	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—RAF1—malignant glioma	4.17e-06	0.000196	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—PIK3CB—malignant glioma	4.16e-06	0.000195	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling by GPCR—PIK3CA—malignant glioma	4.15e-06	0.000195	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—MDM2—malignant glioma	4.13e-06	0.000194	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—ERBB2—malignant glioma	4.13e-06	0.000194	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—RAF1—malignant glioma	4.12e-06	0.000193	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—EGFR—malignant glioma	4.11e-06	0.000193	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—ERBB2—malignant glioma	4.07e-06	0.000191	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—PIK3CB—malignant glioma	4.07e-06	0.000191	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—PIK3CG—malignant glioma	4.02e-06	0.000189	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—PIK3CB—malignant glioma	4.02e-06	0.000189	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—CXCL8—malignant glioma	4e-06	0.000188	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—MYC—malignant glioma	3.96e-06	0.000186	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—CXCL8—malignant glioma	3.91e-06	0.000184	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—PPARG—malignant glioma	3.88e-06	0.000182	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—KRAS—malignant glioma	3.88e-06	0.000182	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—EGFR—malignant glioma	3.87e-06	0.000182	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—CXCL8—malignant glioma	3.86e-06	0.000181	CbGpPWpGaD
Triflupromazine—DRD2—GPCR downstream signaling—AKT1—malignant glioma	3.86e-06	0.000181	CbGpPWpGaD
Triflupromazine—BCHE—Metabolism—PIK3CA—malignant glioma	3.85e-06	0.000181	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—CASP3—malignant glioma	3.83e-06	0.00018	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—IL2—malignant glioma	3.82e-06	0.000179	CbGpPWpGaD
Triflupromazine—CHRM1—GPCR downstream signaling—AKT1—malignant glioma	3.78e-06	0.000177	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—CASP3—malignant glioma	3.75e-06	0.000176	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—IL2—malignant glioma	3.74e-06	0.000175	CbGpPWpGaD
Triflupromazine—CHRM2—GPCR downstream signaling—AKT1—malignant glioma	3.73e-06	0.000175	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—CASP3—malignant glioma	3.7e-06	0.000173	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—IL2—malignant glioma	3.69e-06	0.000173	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—KRAS—malignant glioma	3.66e-06	0.000172	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—MMP9—malignant glioma	3.62e-06	0.00017	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—PTEN—malignant glioma	3.6e-06	0.000169	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—PIK3CA—malignant glioma	3.56e-06	0.000167	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—MMP9—malignant glioma	3.54e-06	0.000166	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—PIK3CD—malignant glioma	3.53e-06	0.000166	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—PTEN—malignant glioma	3.52e-06	0.000165	CbGpPWpGaD
Triflupromazine—DRD2—Signaling by GPCR—AKT1—malignant glioma	3.51e-06	0.000165	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—MMP9—malignant glioma	3.49e-06	0.000164	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—PTEN—malignant glioma	3.47e-06	0.000163	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—TP53—malignant glioma	3.45e-06	0.000162	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling by GPCR—AKT1—malignant glioma	3.43e-06	0.000161	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling by GPCR—AKT1—malignant glioma	3.39e-06	0.000159	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—PIK3CA—malignant glioma	3.36e-06	0.000158	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—TP53—malignant glioma	3.25e-06	0.000152	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—VEGFA—malignant glioma	3.25e-06	0.000152	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—STAT3—malignant glioma	3.22e-06	0.000151	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—VEGFA—malignant glioma	3.18e-06	0.000149	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—STAT3—malignant glioma	3.15e-06	0.000148	CbGpPWpGaD
Triflupromazine—BCHE—Metabolism—AKT1—malignant glioma	3.14e-06	0.000147	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—VEGFA—malignant glioma	3.14e-06	0.000147	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—STAT3—malignant glioma	3.11e-06	0.000146	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—PIK3CB—malignant glioma	3.08e-06	0.000145	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—PTGS2—malignant glioma	3.05e-06	0.000143	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—MYC—malignant glioma	2.99e-06	0.00014	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—MYC—malignant glioma	2.92e-06	0.000137	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—EGFR—malignant glioma	2.92e-06	0.000137	CbGpPWpGaD
Triflupromazine—HTR2B—Signaling Pathways—AKT1—malignant glioma	2.91e-06	0.000137	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—MYC—malignant glioma	2.89e-06	0.000135	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—EGFR—malignant glioma	2.86e-06	0.000134	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—EGFR—malignant glioma	2.82e-06	0.000132	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—KRAS—malignant glioma	2.76e-06	0.00013	CbGpPWpGaD
Triflupromazine—DRD1—Signaling Pathways—AKT1—malignant glioma	2.74e-06	0.000129	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—KRAS—malignant glioma	2.7e-06	0.000127	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—KRAS—malignant glioma	2.67e-06	0.000125	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—PTEN—malignant glioma	2.66e-06	0.000125	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—PIK3CA—malignant glioma	2.54e-06	0.000119	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—PIK3CA—malignant glioma	2.48e-06	0.000116	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—TP53—malignant glioma	2.45e-06	0.000115	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—PIK3CA—malignant glioma	2.45e-06	0.000115	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—TP53—malignant glioma	2.4e-06	0.000113	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—TP53—malignant glioma	2.37e-06	0.000111	CbGpPWpGaD
Triflupromazine—DRD2—Signaling Pathways—AKT1—malignant glioma	2.07e-06	9.72e-05	CbGpPWpGaD
Triflupromazine—CHRM1—Signaling Pathways—AKT1—malignant glioma	2.03e-06	9.51e-05	CbGpPWpGaD
Triflupromazine—CHRM2—Signaling Pathways—AKT1—malignant glioma	2e-06	9.39e-05	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—PIK3CA—malignant glioma	1.88e-06	8.81e-05	CbGpPWpGaD
Triflupromazine—ABCB1—Metabolism—AKT1—malignant glioma	1.53e-06	7.2e-05	CbGpPWpGaD
